Next report date
Report period
H1 2024
EPS estimate
−1.09HKD
Revenue estimate
273.29 MHKD
−933.13 MHKD
139.15 MHKD
153.22 M
Om EVEREST MEDICINES LTD
Sektor
Bransch
VD
Yong Qing Luo
Webbplats
Huvudkvarter
Shanghai
Employees (FY)
432
Grundat
2017
ISIN
KYG3224E1061
FIGI
BBG00XJ8RXX1
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
